
CASI Pharmaceuticals CASI
$ 0.99
-0.01%
Quarterly report 2022-Q3
added 11-14-2022
CASI Pharmaceuticals DIO Ratio 2011-2026 | CASI
Annual DIO Ratio CASI Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 47.4 | 52.1 | 421 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 421 | 47.4 | 174 |
Quarterly DIO Ratio CASI Pharmaceuticals
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 124 | 122 | 68.3 | - | 69.5 | 99 | 84.2 | - | 67.7 | 49.2 | 83.8 | - | 157 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 157 | 49.2 | 92.5 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
136 | - | 4.01 % | $ 150 M | ||
|
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M | ||
|
ANI Pharmaceuticals
ANIP
|
181 | $ 81.6 | -0.49 % | $ 1.58 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
Amgen
AMGN
|
234 | $ 342.65 | -0.08 % | $ 184 B | ||
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Aytu BioScience
AYTU
|
209 | $ 2.63 | 1.74 % | $ 16.5 M | ||
|
Biogen
BIIB
|
394 | $ 178.24 | 1.2 % | $ 26 B | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | ||
|
Catalyst Biosciences
CBIO
|
410 | $ 9.63 | -5.08 % | $ 634 M | ||
|
Berkeley Lights
BLI
|
246 | - | -7.31 % | $ 87 M | ||
|
Amneal Pharmaceuticals
AMRX
|
123 | $ 13.65 | -3.3 % | $ 4.22 B | ||
|
Cerus Corporation
CERS
|
213 | $ 2.32 | -0.22 % | $ 428 M | ||
|
Baudax Bio
BXRX
|
596 | - | 0.59 % | $ 63 K |